These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11795260)

  • 1. Genetic studies on the role of proteinases and growth factors in atherosclerosis and aneurysm formation.
    Luttun A; Carmeliet P
    Ann N Y Acad Sci; 2001 Dec; 947():124-32; discussion 132-3. PubMed ID: 11795260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular proteolysis in the development and progression of atherosclerosis.
    Lijnen HR
    Biochem Soc Trans; 2002 Apr; 30(2):163-7. PubMed ID: 12023844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
    Brown BA; Williams H; George SJ
    Prog Mol Biol Transl Sci; 2017; 147():197-237. PubMed ID: 28413029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases and their inhibitors in human brain tumours: a review.
    Rooprai HK; McCormick D
    Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinases and plaque rupture: unblocking the road to translation.
    Newby AC
    Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and atherogenesis in dependence of age.
    Kunz J
    Gerontology; 2007; 53(2):63-73. PubMed ID: 17047333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proteinases and inhibitors in human breast cancer progression and survival.
    Baker EA; Stephenson TJ; Reed MW; Brown NJ
    Mol Pathol; 2002 Oct; 55(5):300-4. PubMed ID: 12354933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes.
    Asanuma K; Shirato I; Ishidoh K; Kominami E; Tomino Y
    Kidney Int; 2002 Sep; 62(3):822-31. PubMed ID: 12164864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinases in development and progression of vascular disease.
    Lijnen HR
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):275-81. PubMed ID: 15692229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
    Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
    Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue plasminogen activator and plasminogen activator inhibitor gene polymorphisms: possible relation to atherosclerosis and its complications].
    Selezneva ND; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(8):60-7. PubMed ID: 14593385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.